Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**RNA, U2 small nuclear 45, pseudogene (RNU2-45P)** is classified as a *pseudogene* in the human genome[1][6]. It is a member of the RNU2 family, which includes genes encoding U2 small nuclear RNA (snRNA), a key RNA component of the spliceosome complex responsible for pre-mRNA splicing[1]. However, as a pseudogene, RNU2-45P is not known to produce a functional RNA or protein product, nor does it have a defined biological or disease role. It is annotated in gene databases purely as a non-coding, likely non-functional genomic element[1][6].\n\n**Essential context and supporting details:**\n- Unlike functional RNU2 genes (such as RNU2-2, which encode snRNA components of the spliceosome[5]), *RNU2-45P* is specifically labeled as a pseudogene, suggesting it was once functional but has lost its ability to express a functional product[1][6].\n- There is no evidence of its use as a therapeutic target, diagnostic biomarker, or role in disease.\n- Its only established classification is "Other," denoting it as a pseudogene within the non-coding RNA gene family.\n\nNo information was identified regarding interacting drugs, pathways, clinical relevance, or safety concerns[1][6]. If more detailed mapping is required (e.g., for the parent U2 snRNA family or spliceosomal components), this must be searched under the appropriately functional genes, not RNU2-45P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U2 small nuclear 45, pseudogene (RNU2-45P).